Cargando…

Pyruvate Kinase M2 Expression, but Not Pyruvate Kinase Activity, Is Up-Regulated in a Grade-Specific Manner in Human Glioma

Normal tissues express the M1 isoform of pyruvate kinase (PK) that helps generate and funnel pyruvate into the mitochondria for ATP production. Tumors, in contrast, express the less active PKM2 isoform, which limits pyruvate production and spares glycolytic intermediates for the generation of macrom...

Descripción completa

Detalles Bibliográficos
Autores principales: Mukherjee, Joydeep, Phillips, Joanna J., Zheng, Shichun, Wiencke, John, Ronen, Sabrina M., Pieper, Russell O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581484/
https://www.ncbi.nlm.nih.gov/pubmed/23451252
http://dx.doi.org/10.1371/journal.pone.0057610
_version_ 1782260419175383040
author Mukherjee, Joydeep
Phillips, Joanna J.
Zheng, Shichun
Wiencke, John
Ronen, Sabrina M.
Pieper, Russell O.
author_facet Mukherjee, Joydeep
Phillips, Joanna J.
Zheng, Shichun
Wiencke, John
Ronen, Sabrina M.
Pieper, Russell O.
author_sort Mukherjee, Joydeep
collection PubMed
description Normal tissues express the M1 isoform of pyruvate kinase (PK) that helps generate and funnel pyruvate into the mitochondria for ATP production. Tumors, in contrast, express the less active PKM2 isoform, which limits pyruvate production and spares glycolytic intermediates for the generation of macromolecules needed for proliferation. Although high PKM2 expression and low PK activity are considered defining features of tumors, very little is known about how PKM expression and PK activity change along the continuum from low grade to high grade tumors, and how these changes relate to tumor growth. To address this issue, we measured PKM isoform expression and PK activity in normal brain, neural progenitor cells, and in a series of over 100 astrocytomas ranging from benign grade I pilocytic astrocytomas to highly aggressive grade IV glioblastoma multiforme (GBM). All glioma exhibited comparably reduced levels of PKM1 expression and PK activity relative to normal brain. In contrast, while grade I-III gliomas all had modestly increased levels of PKM2 RNA and protein expression relative to normal brain, GBM, regardless of whether they arose de novo or progressed from lower grade tumors, showed a 3–5 fold further increase in PKM2 RNA and protein expression. Low levels of PKM1 expression and PK activity were important for cell growth as PKM1 over-expression and the accompanying increases in PK activity slowed the growth of GBM cells. The increased expression of PKM2, however, was also important, because shRNA-mediated PKM2 knockdown decreased total PKM2 and the already low levels of PK activity, but paradoxically also limited cell growth in vitro and in vivo. These results show that pyruvate kinase M expression, but not pyruvate kinase activity, is regulated in a grade-specific manner in glioma, but that changes in both PK activity and PKM2 expression contribute to growth of GBM.
format Online
Article
Text
id pubmed-3581484
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-35814842013-02-28 Pyruvate Kinase M2 Expression, but Not Pyruvate Kinase Activity, Is Up-Regulated in a Grade-Specific Manner in Human Glioma Mukherjee, Joydeep Phillips, Joanna J. Zheng, Shichun Wiencke, John Ronen, Sabrina M. Pieper, Russell O. PLoS One Research Article Normal tissues express the M1 isoform of pyruvate kinase (PK) that helps generate and funnel pyruvate into the mitochondria for ATP production. Tumors, in contrast, express the less active PKM2 isoform, which limits pyruvate production and spares glycolytic intermediates for the generation of macromolecules needed for proliferation. Although high PKM2 expression and low PK activity are considered defining features of tumors, very little is known about how PKM expression and PK activity change along the continuum from low grade to high grade tumors, and how these changes relate to tumor growth. To address this issue, we measured PKM isoform expression and PK activity in normal brain, neural progenitor cells, and in a series of over 100 astrocytomas ranging from benign grade I pilocytic astrocytomas to highly aggressive grade IV glioblastoma multiforme (GBM). All glioma exhibited comparably reduced levels of PKM1 expression and PK activity relative to normal brain. In contrast, while grade I-III gliomas all had modestly increased levels of PKM2 RNA and protein expression relative to normal brain, GBM, regardless of whether they arose de novo or progressed from lower grade tumors, showed a 3–5 fold further increase in PKM2 RNA and protein expression. Low levels of PKM1 expression and PK activity were important for cell growth as PKM1 over-expression and the accompanying increases in PK activity slowed the growth of GBM cells. The increased expression of PKM2, however, was also important, because shRNA-mediated PKM2 knockdown decreased total PKM2 and the already low levels of PK activity, but paradoxically also limited cell growth in vitro and in vivo. These results show that pyruvate kinase M expression, but not pyruvate kinase activity, is regulated in a grade-specific manner in glioma, but that changes in both PK activity and PKM2 expression contribute to growth of GBM. Public Library of Science 2013-02-25 /pmc/articles/PMC3581484/ /pubmed/23451252 http://dx.doi.org/10.1371/journal.pone.0057610 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration, which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
spellingShingle Research Article
Mukherjee, Joydeep
Phillips, Joanna J.
Zheng, Shichun
Wiencke, John
Ronen, Sabrina M.
Pieper, Russell O.
Pyruvate Kinase M2 Expression, but Not Pyruvate Kinase Activity, Is Up-Regulated in a Grade-Specific Manner in Human Glioma
title Pyruvate Kinase M2 Expression, but Not Pyruvate Kinase Activity, Is Up-Regulated in a Grade-Specific Manner in Human Glioma
title_full Pyruvate Kinase M2 Expression, but Not Pyruvate Kinase Activity, Is Up-Regulated in a Grade-Specific Manner in Human Glioma
title_fullStr Pyruvate Kinase M2 Expression, but Not Pyruvate Kinase Activity, Is Up-Regulated in a Grade-Specific Manner in Human Glioma
title_full_unstemmed Pyruvate Kinase M2 Expression, but Not Pyruvate Kinase Activity, Is Up-Regulated in a Grade-Specific Manner in Human Glioma
title_short Pyruvate Kinase M2 Expression, but Not Pyruvate Kinase Activity, Is Up-Regulated in a Grade-Specific Manner in Human Glioma
title_sort pyruvate kinase m2 expression, but not pyruvate kinase activity, is up-regulated in a grade-specific manner in human glioma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581484/
https://www.ncbi.nlm.nih.gov/pubmed/23451252
http://dx.doi.org/10.1371/journal.pone.0057610
work_keys_str_mv AT mukherjeejoydeep pyruvatekinasem2expressionbutnotpyruvatekinaseactivityisupregulatedinagradespecificmannerinhumanglioma
AT phillipsjoannaj pyruvatekinasem2expressionbutnotpyruvatekinaseactivityisupregulatedinagradespecificmannerinhumanglioma
AT zhengshichun pyruvatekinasem2expressionbutnotpyruvatekinaseactivityisupregulatedinagradespecificmannerinhumanglioma
AT wienckejohn pyruvatekinasem2expressionbutnotpyruvatekinaseactivityisupregulatedinagradespecificmannerinhumanglioma
AT ronensabrinam pyruvatekinasem2expressionbutnotpyruvatekinaseactivityisupregulatedinagradespecificmannerinhumanglioma
AT pieperrussello pyruvatekinasem2expressionbutnotpyruvatekinaseactivityisupregulatedinagradespecificmannerinhumanglioma